Key result
Transvenous extraction of pacemaker and defibrillator leads resulted in an overall one-year survival rate of 92.7%, with infective indications, heart failure, and renal failure significantly increasing mortality risk.
Cohort (n=192)
No
Transvenous lead extraction is a relatively safe procedure with a high one-year survival rate (92.7%), where mortality is significantly associated with underlying heart failure, renal failure, and infective indications rather than the procedure itself.
Answers are grounded in this paper and cite their sources.
Informs risk assessment for device extractions; leaves open need for prospective trials on long-term outcomes.
INTRODUCTION: The number of pacemaker and ICD implantations has increased substantially in the recent years. Therefore, complications are also observed in a greater number. In many cases, transvenous extraction of the previously implanted device (pacemaker or ICD) is the only solution. One may find in the literature information about the efficacy and safety of that procedure, but data concerning the results of long-term follow up are still limited. AIM: The aim of the study was to assess the one-year mortality in the cohort of patients undergoing transvenous lead extraction procedures in our centre. METHODS: Records of the patients undergoing transvenous lead removal in the Department of Cardiology and Electrotherapy of the Medical University of Gdańsk were analyzed. We collected detailed information about 192 patients that had undergone the procedure from January 2003 until June 2012. Data were collected from medical and surgical records. We analyzed concomitant diseases, indications, and possible complications. Long-term follow-up data were gathered in the follow-up ambulatory records and over-the-phone interviews with patients or families. In several cases, we consulted the database of the Polish National Health Fund. RESULTS: During the early post-operative period 5 patients died, although none of those deaths was associated with the procedure itself. No other major complications were observed. During one-year follow-up other 5 patients died, which gave the overall one-year survival rate of 92.7%. Heart failure, renal failure and an infective indication showed significant association with increased mortality. CONCLUSION: Results of transvenous lead extraction, a relatively safe procedure, should be assessed over time extending beyond the sole perioperative period. Some complications may be delayed in their nature, and may be observed only during the long-term follow up.
No takes yet. Share an insight, caveat, or question.
Kempa et al. (2015) conducted a cohort in Patients requiring transvenous extraction of pacemaker and defibrillator leads (n=192). Transvenous lead extraction was evaluated on One-year survival rate. Transvenous extraction of pacemaker and defibrillator leads resulted in an overall one-year survival rate of 92.7%, with infective indications, heart failure, and renal failure significantly increasing mortality risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: